Selected Publications

  1. Ahlstedt J, Johansson E, Sydoff M, Karlsson H, Thordarsson E, Gram M, Eriksson O: Non-invasive imaging methodologies for assessment of radiation damage to bone marrow and kidneys from peptide receptor radionuclide therapy. Neuroendocrinology 2020.
  2. Ando T, Sekine T, Murai Y, Orita E, Takagi R, Amano Y, Iwata K, Nakaza M, Ogawa M, Obara M: Multiparametric flow analysis using four-dimensional flow magnetic resonance imaging can detect cerebral hemodynamic impairment in patients with internal carotid artery stenosis. Neuroradiology 2020.
  3. Andrews JP, Portal C, Walton T, Macaskill MG, Hadoke PW, Alcaide Corral C, Lucatelli C, Wilson S, Wilson I, MacNaught G: Non-invasive in vivo imaging of acute thrombosis: development of a novel factor XIIIa radiotracer. European Heart Journal-Cardiovascular Imaging 2020, 21(6):673-682.
  4. Aohara K, Minatani S, Kimura H, Takeuchi J, Takeda A, Kawabe J, Wada Y, Mawatari A, Watanabe Y, Shimada H: Staging of tau distribution by positron emission tomography may be useful in clinical staging of Alzheimer disease. Neurology and Clinical Neuroscience 2020, 8(2):61-67.
  5. Arakawa R, Takano A, Stenkrona P, Stepanov V, Nag S, Jahan M, Grybäck P, Bolin M, Chen L, Zhang L: PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [18 F] PF-06684511. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-11.
  6. Azevedo PN, Zanirati G, Venturin GT, Schu GG, Durán–Carabali LE, Odorcyk FK, Soares AV, de Oliveira Laguna G, Netto CA, Zimmer ER: Long-term changes in metabolic brain network drive memory impairments in rats following neonatal hypoxia-ischemia. Neurobiology of Learning and Memory 2020:107207.
  7. Babin V, Tournier BB, Davis A, Dubost E, Pigrée G, Lohier J-F, Reboul V, Cailly T, Bouillon J-P, Millet P: Design of iodinated radioligands for SPECT imaging of central human 5-HT4R using a ligand lipophilicity efficiency approach. Bioorganic Chemistry 2020, 96:103582.
  8. Bai P, Bai S, Placzek MS, Lu X, Fiedler SA, Ntaganda B, Wey H-Y, Wang C: A New Positron Emission Tomography Probe for Orexin Receptors Neuroimaging. Molecules 2020, 25(5):1018.
  9. Bai P, Lu X, Lan Y, Chen Z, Patnaik D, Fiedler S, Striar R, Haggarty SJ, Wang C: Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins. Nuclear Medicine and Biology 2020.
  10. Barrett HE, Meester EJ, van Gaalen K, van der Heiden K, Krenning BJ, Beekman FJ, de Blois E, de Swart J, Verhagen H, Maina T: Imaging of inflammatory cellular protagonists in human atherosclerosis: a dual-isotope SPECT approach. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-10.
  11. Barron AM, Ji B, Fujinaga M, Zhang M-R, Suhara T, Sahara N, Aoki I, Tsukada H, Higuchi M: In vivo PET imaging of mitochondrial abnormalities in a mouse model of tauopathy. Neurobiology of Aging 2020.
  12. Bascuñana P, Brackhan M, Leiter I, Keller H, Jahreis I, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP: Divergent metabolic substrate utilization in brain during epileptogenesis precedes chronic hypometabolism. Journal of Cerebral Blood Flow & Metabolism 2020, 40(1):204-213.
  13. Bascuñana P, Hess A, Borchert T, Wang Y, Wollert KC, Bengel FM, Thackeray JT: 11C-Methionine PET Identifies Astroglia Involvement in Heart–Brain Inflammation Networking After Acute Myocardial Infarction. Journal of Nuclear Medicine 2020, 61(7):977-980.
  14. Bashir A, Binderup T, Vestergaard MB, Broholm H, Marner L, Ziebell M, Fugleholm K, Kjaer A, Law I: In vivo imaging of cell proliferation in meningioma using 3′-deoxy-3′-[18 F] fluorothymidine PET/MRI. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-14.
  15. Bashir A, Vestergaard MB, Binderup T, Broholm H, Marner L, Ziebell M, Fugleholm K, Mathiesen T, Kjær A, Law I: Pharmacokinetic analysis of [68 Ga] Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-12.
  16. Bastin C, Bahri MA, Meyer F, Manard M, Delhaye E, Plenevaux A, Becker G, Seret A, Mella C, Giacomelli F: In vivo imaging of synaptic loss in Alzheimer’s disease with [18F] UCB-H positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging 2020, 47(2):390-402.
  17. Bauer EK, Stoffels G, Blau T, Reifenberger G, Felsberg J, Werner JM, Lohmann P, Rosen J, Ceccon G, Tscherpel C: Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18 F]-fluoroethyl)-l-tyrosine PET. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-10.
  18. Becker G, Dammicco S, Bahri MA, Salmon E: The Rise of Synaptic Density PET Imaging. Molecules 2020, 25(10):2303.
  19. Beinat C, Patel CB, Haywood T, Shen B, Naya L, Gandhi H, Holley D, Khalighi M, Iagaru A, Davidzon G: Human biodistribution and radiation dosimetry of [18 F] DASA-23, a PET probe targeting pyruvate kinase M2. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-8.
  20. Belderbos S, González-Gómez MA, Cleeren F, Wouters J, Piñeiro Y, Deroose CM, Coosemans A, Gsell W, Bormans G, Rivas J: Simultaneous in vivo PET/MRI using fluorine-18 labeled Fe 3 O 4@ Al (OH) 3 nanoparticles: comparison of nanoparticle and nanoparticle-labeled stem cell distribution. EJNMMI research 2020, 10(1):1-13.
  21. Bertoglio D, Verhaeghe J, Korat Š, Miranda A, Cybulska K, Wyffels L, Stroobants S, Mrzljak L, Dominguez C, Skinbjerg M: Elevated Type 1 Metabotropic Glutamate Receptor Availability in a Mouse Model of Huntington’s Disease: a Longitudinal PET Study. Molecular neurobiology 2020:1-10.
  22. Bertoglio D, Verhaeghe J, Miranda A, Kertesz I, Cybulska K, Korat Š, Wyffels L, Stroobants S, Mrzljak L, Dominguez C: Validation and noninvasive kinetic modeling of [11C] UCB-J PET imaging in mice. Journal of Cerebral Blood Flow & Metabolism 2020, 40(6):1351-1362.
  23. Beyer L, Brendel M, Scheiwein F, Sauerbeck J, Hosakawa C, Alberts I, Shi K, Bartenstein P, Ishii K, Seibyl J: Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer’s Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography. Journal of Alzheimer’s Disease 2020(Preprint):1-12.
  24. Beyer L, Nitschmann A, Barthel H, van Eimeren T, Unterrainer M, Sauerbeck J, Marek K, Song M, Palleis C, Respondek G: Early-phase [18 F] PI-2620 tau-PET imaging as a surrogate marker of neuronal injury. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-12.
  25. Biegon A, Shroyer KR, Franceschi D, Dhawan J, Tahmi M, Pareto D, Bonilla P, Airola K, Cohen J: Initial Studies with 11C-Vorozole PET Detect Overexpression of Intratumoral Aromatase in Breast Cancer. Journal of Nuclear Medicine 2020, 61(6):807-813.
  26. Boles Ponto LL, Magnotta VA, Menda Y, Moser DJ, Oleson JJ, Harlynn EL, DeVries SD, Wemmie JA, Schultz SK: Comparison of T1Rho MRI, Glucose Metabolism, and Amyloid Burden Across the Cognitive Spectrum: A Pilot Study. The Journal of Neuropsychiatry and Clinical Neurosciences 2020:appi. neuropsych. 19100221.
  27. Borchert T, Hess A, Lukačević M, Ross TL, Bengel FM, Thackeray JT: Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation. European journal of nuclear medicine and molecular imaging 2020:1-12.
  28. Bremova-Ertl T, Sztatecsny C, Brendel M, Moser M, Möller B, Clevert DA, Beck-Wödl S, Kun-Rodrigues C, Bras J, Rominger A: Clinical, ocular motor, and imaging profile of Niemann-Pick type C heterozygosity. Neurology 2020, 94(16):e1702-e1715.
  29. Bullich S, Barret O, Constantinescu C, Sandiego C, Mueller A, Berndt M, Papin C, Perrotin A, Koglin N, Kroth H: Evaluation of Dosimetry, Quantitative Methods, and Test–Retest Variability of 18F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain. Journal of Nuclear Medicine 2020, 61(6):920-927.
  30. Cai L, Liow J-S, Morse CL, Telu S, Davies R, Frankland MP, Zoghbi S, Cheng K, Hall M, Innis RB: Evaluation of 11C-NR2B-SMe and its Enantiomers as PET Radioligands for Imaging the NR2B Subunit within the NMDA Receptor Complex in Rats. Journal of Nuclear Medicine 2020:jnumed. 119.235143.
  31. Cai X, Zhang K, Xie X, Zhu X, Feng J, Jin Z, Zhang H, Tian M, Chen H: Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline. Biomaterials 2020, 231:119678.
  32. Cao R, Chen X, Xie C, Hu P, Wang K: Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson’s Disease With Probable REM Sleep Behavior Disorder. Frontiers in Neuroscience 2020, 14:349.
  33. Ceballos-Francisco D, García-Carrillo N, Cuesta A, Esteban MÁ: Radiological characterization of gilthead seabream (Sparus aurata) fat by X-ray micro-computed tomography. Scientific RepoRtS 2020, 10(1):1-11.
  34. Ceccarini J, Leurquin-Sterk G, Crunelle CL, De Laat B, Bormans G, Peuskens H, Van Laere K: Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent patients. Journal of Nuclear Medicine 2020, 61(2):256-262.
  35. Chang WH, Chen KC, Tseng H-H, Chiu NT, Lee IH, Chen PS, Yang YK: Bridging the associations between dopamine, brain volumetric variation and IQ in drug-naïve schizophrenia. Schizophrenia Research 2020.
  36. Chastel A, Worm DJ, Alves ID, Vimont D, Petrel M, Fernandez S, Garrigue P, Fernandez P, Hindié E, Beck-Sickinger AG: Design, synthesis, and biological evaluation of a multifunctional neuropeptide-Y conjugate for selective nuclear delivery of radiolanthanides. EJNMMI research 2020, 10(1):1-12.
  37. Chen K-H, Miao Y-B, Shang C-Y, Huang T-Y, Yu Y-T, Yeh C-N, Song H-L, Chen C-T, Mi F-L, Lin K-J: A bubble bursting-mediated oral drug delivery system that enables concurrent delivery of lipophilic and hydrophilic chemotherapeutics for treating pancreatic tumors in rats. Biomaterials 2020:120157.
  38. Chen Y, Goorden MC, Vastenhouw B, Beekman FJ: Optimized sampling for high resolution multi-pinhole brain SPECT with stationary detectors. Physics in Medicine & Biology 2020, 65(1):015002.
  39. Choi BW, Kim S, Kang S, Won KS, Yi H-A, Kim HW: Relationship between thyroid hormone levels and the pathology of Alzheimer’s disease in euthyroid subjects. Thyroid 2020(ja).
  40. Cisbani G, Koppel A, Knezevic D, Suridjan I, Mizrahi R, Bazinet RP: Peripheral cytokine and fatty acid associations with neuroinflammation in AD and aMCI patients: an exploratory study. Brain, Behavior, and Immunity 2020.
  41. Coda A, Anzilotti S, Boscia F, Greco A, Panico M, Gargiulo S, Gramanzini M, Zannetti A, Albanese S, Pignataro G: In vivo imaging of CNS microglial activation/macrophage infiltration with combined [18 F] DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-13.
  42. Cole K, Pugh T, Cornejo K, Chareonthaitawee P, Johnson G, Kemp B: Clinical evaluation of software for processing 13N-ammonia rest-stress cardiac perfusion PET/CT studies. Journal of Nuclear Medicine 2020, 61(supplement 1):3060-3060.
  43. Craciun L, de Wind R, Demetter P, Lucidi V, Bohlok A, Michiels S, Bouazza F, Vouche M, Tancredi I, Verset G: Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy. BMC cancer 2020, 20(1):1-10.
  44. Cuenoud B, Hartweg M, Godin J-P, Croteau E, Maltais M, Castellano C-A, Carpentier AC, Cunnane SC: Metabolism of exogenous D-beta-hydroxybutyrate, an energy substrate avidly consumed by the heart and kidney. Frontiers in nutrition 2020, 7:13.
  45. Damuka N, Czoty PW, Davis AT, Nader MA, Nader SH, Craft S, Macauley SL, Galbo LK, Epperly PM, Whitlow CT: PET Imaging of [11C] MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains. Molecules 2020, 25(10):2289.
  46. Darr C, Harke N, Radtke JP, Yirga L, Kesch C, Grootendorst M, Fendler W, Costa PF, Rischpler C, Praus C: Intraoperative 68Gallium-PSMA Cerenkov Luminescence Imaging for surgical margins in radical prostatectomy–a feasibility study. Journal of Nuclear Medicine 2020:jnumed. 119.240424.
  47. de Arcocha-Torres M, Quincoces G, Martínez-López A, Erhard A, Collantes M, Martínez-Rodríguez I, Ecay M, Banzo I, Irache J, Peñuelas I: Preparation, radiolabeling with 99mTc and 67Ga and biodistribution studies of albumin nanoparticles coated with polymers. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2020.
  48. De Leo TC, dos Santos SN, Andrade CDC, Ricci E, Turato WM, Lopes NP, Oliveira RS, Bernardes ES, Dias-Baruffi M: Engineering of galectin-3 for glycan-binding optical imaging. Biochemical and Biophysical Research Communications 2020, 521(3):674-680.
  49. de Redín IL, Expósito F, Agüeros M, Collantes M, Peñuelas I, Allemandi D, Llabot JM, Calvo A, Irache JM: In vivo efficacy of bevacizumab-loaded albumin nanoparticles in the treatment of colorectal cancer. Drug Delivery and Translational Research 2020:1-11.
  50. Delva A, Van Weehaeghe D, van Aalst J, Ceccarini J, Koole M, Baete K, Nuyts J, Vandenberghe W, Van Laere K: Quantification and discriminative power of 18 F-FE-PE2I PET in patients with Parkinson’s disease. European journal of nuclear medicine and molecular imaging 2020, 47(8):1913-1926.
  51. Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C: Kinetic modeling and parametric imaging with dynamic PET for oncological applications: General considerations, current clinical applications, and future perspectives. Eur J Nucl Med Mol Imaging 2020.
  52. Donat CK, Hansen HH, Hansen HD, Mease RC, Horti AG, Pomper MG, L’Estrade ET, Herth MM, Peters D, Knudsen GM: In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [125I] Iodo-ASEM and [18F] ASEM as Radiotracers of Homo-and Heteromeric α7 Nicotinic Acetylcholine Receptors. Molecules 2020, 25(6):1425.
  53. Doot RK, Young AJ, Daube-Witherspoon ME, Alexoff D, Labban KJ, Lee H, Wu Z, Zha Z, Choi SR, Ploessl KH: Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [68Ga] Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies. Nuclear Medicine and Biology 2020.
  54. Du Y, Minn I, Foss C, Lesniak WG, Hu F, Dannals RF, Pomper MG, Horti AG: PET imaging of soluble epoxide hydrolase in non-human primate brain with [18 F] FNDP. EJNMMI research 2020, 10(1):1-12.
  55. Dubol M, Trichard C, Leroy C, Granger B, Tzavara ET, Martinot J-L, Artiges E: Lower midbrain dopamine transporter availability in depressed patients: Report from high-resolution PET imaging. Journal of Affective Disorders 2020, 262:273-277.
  56. Facchin C, Perez-Liva M, Garofalakis A, Viel T, Certain A, Balvay D, Yoganathan T, Woszczyk J, De Sousa K, Sourdon J: Concurrent imaging of vascularization and metabolism in a mouse model of paraganglioma under anti-angiogenic treatment. Theranostics 2020, 10(8):3518.
  57. Falciani C, Zevolini F, Brunetti J, Riolo G, Gracia R, Marradi M, Loinaz I, Ziemann C, Cossío U, Llop J: Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections. International Journal of Nanomedicine 2020, 15:1117.
  58. Fang J, Ohba H, Hashimoto F, Tsukada H, Chen F, Liu H: Imaging mitochondrial complex I activation during a vibrotactile stimulation: A PET study using [18F] BCPP-EF in the conscious monkey brain. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X19900034.
  59. Fedorova TD, Knudsen K, Hartmann B, Holst JJ, Viborg Mortensen F, Krogh K, Borghammer P: In vivo positron emission tomography imaging of decreased parasympathetic innervation in the gut of vagotomized patients. Neurogastroenterology & Motility 2020, 32(3):e13759.
  60. Fiedorowicz M, Khan M, Strzemecki D, Orzeł J, Wełniak-Kamińska M, Sobiborowicz A, Wieteska M, Rogulski Z, Cheda L, Wargocka-Matuszewska W: Renal carcinoma CD105−/CD44− cells display stem-like properties in vitro and form aggressive tumors in vivo. Scientific reports 2020, 10(1):1-19.
  61. Flanigan M, Tollefson S, Himes ML, Jordan R, Roach K, Stoughton C, Lopresti B, Mason NS, Ciccocioppo R, Narendran R: Acute elevations in cortisol increase the in vivo binding of [11C] NOP-1A to nociceptin receptors: A novel imaging paradigm to study the interaction between stress-and antistress-regulating neuropeptides. Biological Psychiatry 2020, 87(6):570-576.
  62. Fuenfgeld B, Mächler P, Fischer DR, Esposito G, Rushing EJ, Kaufmann PA, Stolzmann P, Huellner MW: Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination. Plos one 2020, 15(4):e0230618.
  63. Fung LK, Flores RE, Gu M, Sun KL, James D, Schuck RK, Jo B, Park JH, Lee BC, Jung JH: Thalamic and prefrontal GABA concentrations but not GABA A receptor densities are altered in high-functioning adults with autism spectrum disorder. Molecular Psychiatry 2020:1-13.
  64. García-Varela L, Vállez García D, Rodríguez-Pérez M, van Waarde A, Sijbesma JrW, Schildt A, Kwizera C, Aguiar P, Sobrino T, Dierckx RA: Test–Retest Repeatability of [18F] MC225-PET in Rodents: A Tracer for Imaging of P-gp Function. ACS chemical neuroscience 2020, 11(4):648-658.
  65. Garrido A, Iranzo A, Stefani A, Serradell M, Muñoz‐Lopetegi A, Marrero P, Högl B, Gaig C, Santamaria J, Tolosa E: Lack of Asymmetry of Nigrostriatal Dopaminergic Function in Healthy Subjects. Movement Disorders 2020.
  66. Gersel Stokholm M, Iranzo A, Østergaard K, Serradell M, Otto M, Bacher Svendsen K, Garrido A, Vilas D, Fedorova TD, Santamaria J: Cholinergic denervation in idiopathic rapid eye movement sleep behaviour disorder patients. Eur j neurol 2019.
  67. Ghadery C, Koshimori Y, Christopher L, Kim J, Rusjan P, Lang AE, Houle S, Strafella AP: The interaction between neuroinflammation and β-amyloid in cognitive decline in Parkinson’s Disease. Molecular neurobiology 2020, 57(1):492-501.
  68. Giacobbo BL, Doorduin J, Moraga-Amaro R, Nazario LR, Schildt A, Bromberg E, Dierckx RA, de Vries EF: Chronic harmine treatment has a delayed effect on mobility in control and socially defeated rats. Psychopharmacology 2020:1-12.
  69. Girard A, Saint-Jalmes H, Chaboub N, Le Reste P-J, Metais A, Devillers A, Le Jeune F, Palard-Novello X: Optimization of time frame binning for FDOPA uptake quantification in glioma. Plos one 2020, 15(4):e0232141.
  70. Giridharan VV, Collodel A, Generoso JS, Scaini G, Wassather R, Selvaraj S, Hasbun R, Dal-Pizzol F, Petronilho F, Barichello T: Neuroinflammation trajectories precede cognitive impairment after experimental meningitis—evidence from an in vivo PET study. Journal of Neuroinflammation 2020, 17(1):1-20.
  71. Glorie D, Verhaeghe J, Miranda A, Kertesz I, Wyffels L, Stroobants S, Staelens S: Progression of obsessive compulsive disorder-like grooming in Sapap3 knockout mice: A longitudinal [11C] ABP688 PET study. Neuropharmacology 2020:108160.
  72. Gnesin S, Kieffer C, Zeimpekis K, Papazyan J-P, Guignard R, Prior JO, Verdun FR, Lima TV: Phantom-based image quality assessment of clinical 18 F-FDG protocols in digital PET/CT and comparison to conventional PMT-based PET/CT. EJNMMI physics 2020, 7(1):1-16.
  73. Gnesin S, Müller J, Burger IA, Meisel A, Siano M, Früh M, Choschzick M, Müller C, Schibli R, Ametamey SM: Radiation dosimetry of 18 F-AzaFol: A first in-human use of a folate receptor PET tracer. EJNMMI research 2020, 10:1-12.
  74. Gruber L, Jimenez-Franco LD, Decristoforo C, Uprimny C, Glatting G, Hohenberger P, Schoenberg SO, Reindl W, Orlandi F, Mariani M: MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of 68Ga-NeoBOMB1, a Gastrin-releasing Peptide Receptor Antagonist, in GIST Patients. Journal of Nuclear Medicine 2020:jnumed. 119.238808.
  75. Guibbal F, Hopkins SL, Pacelli A, Isenegger PG, Mosley M, Torres JB, Dias GM, Mahaut D, Hueting R, Gouverneur V: [18 F] AZD2461, an Insight on Difference in PARP Binding Profiles for DNA Damage Response PET Imaging. Molecular Imaging and Biology 2020:1-9.
  76. Harris DA, Mina A, Cabarkapa D, Heshmati K, Subramaniam R, Banks AS, Tavakkoli A, Sheu EG: Sleeve Gastrectomy enhances glucose utilization and remodels adipose tissue independent of weight loss. American Journal of Physiology-Endocrinology and Metabolism 2020, 318(5):E678-E688.
  77. Hauser EB, Venturin GT, Greggio S, Borelli WV, DaCosta J: Carotid arterial input function as an inverse problem in kinetic modeling of [18F] 2-fluoro-2 deoxy-D-glucose (FDG). Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2020, 8(3):273-276.
  78. Hayashi H, Kobayashi R, Kawakatsu S, Morioka D, Otani K: Utility of Easy Z-Score Imaging System-Assisted SPECT in Detecting Onset Age-Dependent Decreases in Cerebral Blood Flow in the Posterior Cingulate Cortex, Precuneus, and Parietal Lobe in Alzheimer’s Disease with Amyloid Accumulation. Dementia and Geriatric Cognitive Disorders Extra 2020, 10(2):63-68.
  79. He RY, Lai XM, Sun CS, Kung TS, Hong JY, Jheng YS, Liao WN, Chen JK, Liao YF, Tu PH: Nanoscopic insights of amphiphilic peptide against the oligomer assembly process to treat Huntington’s disease. Advanced Science 2020, 7(2):1901165.
  80. He Y, Whitehead D, Briard E, Numao S, Mu L, Schibli R, Ametamey S, Auberson YP: Evaluation of 5H‐thiazolo [3, 2‐a] pyrimidin‐5‐ones as potential GluN2A PET tracers. ChemMedChem 2020.
  81. Hepp T, Othman A, Liebgott A, Kim JH, Pfannenberg C, Gatidis S: Effects of simulated dose variation on contrast-enhanced CT-based radiomic analysis for Non-Small Cell Lung Cancer. European Journal of Radiology 2020, 124:108804.
  82. Hernández Lozano I, Langer O: Use of imaging to assess the activity of hepatic transporters. Expert Opinion on Drug Metabolism & Toxicology 2020, 16(2):149-164.
  83. Hirai N, Watabe T, Nagamori S, Wiriyasermkul P, Tanaka Y, Romanov V, Naka S, Kanai Y, Liu Y, Tani N: Evaluation of D-isomer of 18F-FBPA for oncology PET focusing on the differentiation of glioma and inflammation. Asia Oceania Journal of Nuclear Medicine and Biology 2020, 8(2):102-108.
  84. Houben RH, Kotsougiani D, Friedrich PF, Shin AY, Bishop AT: Outcomes of Vascularized Bone Allotransplantation with Surgically Induced Autogenous Angiogenesis in a Large Animal Model: Bone Healing, Remodeling, and Material Properties. Journal of reconstructive microsurgery 2020, 36(02):082-092.
  85. Houben RH, Thaler R, Kotsougiani D, Friedrich PF, Shin AY, van Wijnen AJ, Bishop AT: Neo‐Angiogenesis, Transplant Viability, and Molecular Analyses of Vascularized Bone Allotransplantation Surgery in a Large Animal Model. Journal of Orthopaedic Research® 2020, 38(2):288-296.
  86. Hsu M-N, Huang K-L, Yu F-J, Lai P-L, Truong AV, Lin M-W, Nguyen NTK, Shen C-C, Hwang S-M, Chang Y-H: Coactivation of endogenous Wnt10b and Foxc2 by CRISPR activation enhances BMSC osteogenesis and promotes calvarial bone regeneration. Molecular Therapy 2020, 28(2):441-451.
  87. Hsu M-N, Yu F-J, Chang Y-H, Huang K-L, Pham NN, Truong VA, Lin M-W, Nguyen NTK, Hwang S-M, Hu Y-C: CRISPR interference-mediated noggin knockdown promotes BMP2-induced osteogenesis and calvarial bone healing. Biomaterials 2020:120094.
  88. Huang CW, Chang YH, Lee HH, Wu JY, Huang JX, Chung YH, Hsu ST, Chow LP, Wei KC, Huang FT: Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma. The FASEB Journal 2020.
  89. Huang S-Y, Hsu J-L, Lin K-J, Hsiao I-T: A novel Individual metabolic brain network for 18F-FDG PET imaging. Frontiers in Neuroscience 2020, 14:344.
  90. Huber FA, Schumann P, Von Spiczak J, Wurnig MC, Klarhöfer M, Finkenstaedt T, Bedogni A, Guggenberger R: Medication-Related Osteonecrosis of the Jaw—Comparison of Bone Imaging Using Ultrashort Echo-Time Magnetic Resonance Imaging and Cone-Beam Computed Tomography. Investigative Radiology 2020, 55(3):160-167.
  91. Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R: Metabolic correlates of dopaminergic loss in dementia with lewy bodies. Movement disorders 2020, 35(4):595-605.
  92. Ito Y, Tada T, Murayama R, Ikeda H, Ochi Y, Tamura M, Tsutsumi Y, Kato K: Studies on Calculation of the Specific Binding Ratio with the Minimum Partial Volume Effect for the Caudate and Putamen by Generating the Analogy Image to the Image Obtained by SPECT Imaging. Journal of Nuclear Medicine 2020, 61(supplement 1):3130-3130.
  93. Jiang D, Kong Y, Ren S, Cai H, Zhang Z, Huang Z, Peng F, Hua F, Guan Y, Xie F: Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT. Nuclear Medicine and Biology 2020, 82:89-95.
  94. Jiang D, Qiu X, Ren S, Hua F, Kong Y, Guan Y, Xie F: Maturation of topological organization of brain networks in male adolescent rats: A longitudinal FDG-PET study. Neuroscience Letters 2020:134864.
  95. Jiménez-González S, Marín-Royo G, Jurado-López R, Bartolomé MV, Romero-Miranda A, Luaces M, Islas F, Nieto ML, Martínez-Martínez E, Cachofeiro V: The Crosstalk between Cardiac Lipotoxicity and Mitochondrial Oxidative Stress in the Cardiac Alterations in Diet-Induced Obesity in Rats. Cells 2020, 9(2):451.
  96. Johnson TB, Brudvig JJ, Lehtimäki KK, Cain JT, White KA, Bragge T, Rytkönen J, Huhtala T, Timm D, Vihma M: A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease. Progress in Neurobiology 2020:101789.
  97. Kang Y, Rúa SMH, Kaunzner UW, Perumal J, Nealon N, Qu W, Kothari PJ, Vartanian T, Kuceyeski A, Gauthier SA: A Multi-Ligand Imaging Study Exploring GABAergic Receptor Expression and Inflammation in Multiple Sclerosis. multiple sclerosis 2020, 4:12-14.
  98. Kato H, Okuno T, Isohashi K, Koda T, Shimizu M, Mochizuki H, Nakatsuji Y, Hatazawa J: Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X20911469.
  99. Kautzky A, Vanicek T, Philippe C, Kranz G, Wadsak W, Mitterhauser M, Hartmann A, Hahn A, Hacker M, Rujescu D: Machine learning classification of ADHD and HC by multimodal serotonergic data. Translational psychiatry 2020, 10(1):1-9.
  100. Kessler M, Mamach M, Beutelmann R, Lukacevic M, Eilert S, Bascuñana P, Fasel A, Bengel F, Bankstahl J, Ross T: GABA A receptors in the mongolian gerbil: A PET study using [18 F] flumazenil to determine receptor binding in young and old animals. Molecular imaging and biology 2020, 22(2):335-347.
  101. Khalmuratova R, Lee M, Park J-W, Shin H-W: Evaluation of Neo-Osteogenesis in Eosinophilic Chronic Rhinosinusitis Using a Nasal Polyp Murine Model. Allergy, Asthma & Immunology Research 2020, 12(2):306-321.
  102. Kim K, Son SM, Goh TS, Pak K, Kim I-J, Lee JS, Kim S-J: Prediction of Response to Tumor Necrosis Value–α Blocker Is Suggested by 18F-NaF SUVmax But Not by Quantitative Pharmacokinetic Analysis in Patients With Ankylosing Spondylitis. American Journal of Roentgenology 2020:1-7.
  103. Kim M-J, Lee J-H, Anaya FJ, Hong J, Miller W, Telu S, Singh P, Cortes MY, Henry K, Tye GL: First-in-human evaluation of [11C] PS13, a novel PET radioligand, to quantify cyclooxygenase-1 in the brain. European journal of nuclear medicine and molecular imaging 2020.
  104. Kim SE, Joo YH, Son YD, Kim HK, Lee SY, Lee MW, Ido T, Kim JH: Association between human gray matter metabotropic glutamate receptor‑5 availability in vivo and white matter properties: a [11C] ABP688 PET and diffusion tensor imaging study. Brain Structure & Function 2020.
  105. Kjærgaard K, Weber B, Alstrup AKO, Petersen JBB, Hansen R, Hamilton-Dutoit SJ, Mortensen FV, Sørensen M: Hepatic regeneration following radiation-induced liver injury is associated with increased hepatobiliary secretion measured by PET in Göttingen minipigs. Scientific Reports 2020, 10(1):1-10.
  106. Klinge MW, Borghammer P, Lund S, Fedorova T, Knudsen K, Haase AM, Christiansen JJ, Krogh K: Enteric cholinergic neuropathy in patients with diabetes: Non‐invasive assessment with positron emission tomography. Neurogastroenterology & Motility 2020, 32(1):e13731.
  107. Knight JC, Torres JB, Goldin R, Mosley M, Dias GM, Bravo LC, Kersemans V, Allen PD, Mukherjee S, Smart S: Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling. Journal of Nuclear Medicine 2020, 61(7):1006-1013.
  108. Ko K-Y, Wang S-Y, Yen R-F, Shiau Y-C, Hsu J-C, Tsai H-Y, Lee C-L, Chiu K-M, Wu Y-W: Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy. Journal of Nuclear Cardiology 2020, 27(1):269-279.
  109. Koole M, Van Weehaeghe D, Serdons K, Herbots M, Cawthorne C, Celen S, Schroeder FA, Hooker JM, Bormans G, de Hoon J: Clinical validation of the novel HDAC6 radiotracer [18 F] EKZ-001 in the human brain. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-16.
  110. Kosinski M, Figiel-Dabrowska A, Lech W, Wieprzowski L, Strzalkowski R, Strzemecki D, Cheda L, Lenart J, Domanska-Janik K, Sarnowska A: Bone Defect Repair Using a Bone Substitute Supported by Mesenchymal Stem Cells Derived from the Umbilical Cord. Stem Cells International 2020, 2020.
  111. Kramer V, Brooks AF, Haeger A, Kuljis RO, Rafique W, Koeppe RA, Raffel DM, Frey KA, Amaral H, Scott PJ: Evaluation of [18F]-N-Methyl lansoprazole as a Tau PET Imaging Agent in First-in-Human Studies. ACS Chemical Neuroscience 2020, 11(3):427-435.
  112. Kramer V, Dyssegaard A, Flores J, Soza-Ried C, Rösch F, Knudsen GM, Amaral H, Herth MM: Characterization of the serotonin 2A receptor selective PET tracer (R)-[18 F] MH. MZ in the human brain. European Journal of Nuclear Medicine and Molecular Imaging 2020, 47(2):355-365.
  113. Kühnel C, Seifert P, Mulik C, Winkens T, Freesmeyer M: 3D printing of fillable individual thyroid replicas based on nuclear medicine DICOM data used as phantoms for gamma probe calibration. Nuklearmedizin 2020, 59(01):12-19.
  114. Kumamoto K, Katsube S, Tsubaki Y, Sato H, Tsutsui Y, Himuro K, Baba S, Sasaki M: Comparison of continuous bed motion and step-and-shoot method in SiPM PET/CT. Journal of Nuclear Medicine 2020, 61(supplement 1):3017-3017.
  115. Kushchayeva YS, Startzell M, Cochran E, Auh S, Sekizkardes H, Soldin SJ, Kushchayev SV, Dieckmann W, Skarulis M, Abdul Sater Z: Thyroid hormone effects on glucose disposal in patients with insulin receptor mutations. The Journal of Clinical Endocrinology & Metabolism 2020, 105(3):e158-e171.
  116. LAN Y, Bai P, Wang H, Wang C: Design and preclinical evaluation of [18F] CNY-05, a next generation of sigma-1 receptor (ó1R) radiotracer for brain imaging of positron emission tomography (PET). Journal of Nuclear Medicine 2020, 61(supplement 1):202-202.
  117. LAN Y, Bai P, Wang H, Wang C: Design and preclinical evaluation of [11C] CNY-06, the firest generation of RIPK1/necroptosis radiotracer for brain imaging of positron emission tomography (PET). Journal of Nuclear Medicine 2020, 61(supplement 1):1035-1035.
  118. Landau AM, Noer O, Alstrup AKO, Audrain H, Wegener G, Gjedde A, Doudet DJ, Winterdahl M: Type of Anaesthetic Influences [11 C] MDL100, 907 Binding to 5HT 2A Receptors in Porcine Brain. Molecular Imaging and Biology 2020:1-8.
  119. Larsen B, Olafsson V, Calabro F, Laymon C, Tervo-Clemmens B, Campbell E, Minhas D, Montez D, Price J, Luna B: Maturation of the human striatal dopamine system revealed by PET and quantitative MRI. Nature communications 2020, 11(1):1-10.
  120. Laurikainen H, Vuorela A, Toivonen A, Reinert-Hartwall L, Trontti K, Lindgren M, Keinänen J, Mäntylä T, Paju J, Ilonen T: Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function. Translational psychiatry 2020, 10(1):1-14.
  121. Ledermann K, Hasler G, Jenewein J, Sprott H, Schnyder U, Martin‐Soelch C: 5ʹUTR polymorphism in the serotonergic receptor HTR3A gene is differently associated with striatal Dopamine D2/D3 receptor availability in the right putamen in Fibromyalgia patients and healthy controls—Preliminary evidence. Synapse 2020, 74(5):e22147.
  122. Lee J-H, Go Y, Kim D-Y, Lee SH, Kim O-H, Jeon YH, Kwon TK, Bae J-H, Song D-K, Lee I-K: Isocitrate dehydrogenase 2 protects mice from high-fat diet-induced metabolic stress by limiting oxidative damage to the mitochondria from brown adipose tissue. Experimental & molecular medicine 2020, 52(2):238-252.
  123. L’Estrade ET, Shalgunov V, Edgar FG, Strebl‐Bantillo MG, Xiong M, Crestey F, Neelamegam R, Dyssegaard A, Lehel S, Erlandsson M: Radiosynthesis and preclinical evaluation of [11C] Cimbi‐701–Towards the imaging of cerebral 5‐HT7 receptors. Journal of Labelled Compounds and Radiopharmaceuticals 2020, 63(2):46-55.
  124. Li CH, Fan SP, Chen TF, Chiu MJ, Yen RF, Lin CH: Frontal variant of Alzheimer’s disease with asymmetric presentation mimicking frontotemporal dementia: Case report and literature review. Brain and Behavior 2020, 10(3):e01548.
  125. Li LLL, Kuo H-T, Wang X, Merkens H, Colpo N, Radchenko V, Schaffer P, Lin K-S, Benard F, Orvig C: tBu4octapa-alkyl-NHS for Metalloradiopeptide Preparation. Dalton Transactions 2020.
  126. Lin H-C, Chan S-C, Cheng N-M, Liao C-T, Hsu C-L, Wang H-M, Lin C-Y, Chang JT-C, Ng S-H, Yang L-Y: Pretreatment 18F-FDG PET/CT texture parameters provide complementary information to Epstein-Barr virus DNA titers in patients with metastatic nasopharyngeal carcinoma. Oral Oncology 2020, 104:104628.
  127. Lindemann M, Moldovan R-P, Hinz S, Deuther-Conrad W, Gündel D, Dukic-Stefanovic S, Toussaint M, Teodoro R, Juhl C, Steinbach J: Development of a Radiofluorinated Adenosine A2B Receptor Antagonist as Potential Ligand for PET Imaging. International journal of molecular sciences 2020, 21(9):3197.
  128. Liu R, Umbach DM, Tröster AI, Huang X, Chen H: Non-motor symptoms and striatal dopamine transporter binding in early Parkinson’s disease. Parkinsonism & Related Disorders 2020, 72:23-30.
  129. Liu S, Li Y, Fan X, Li K, Xu C, Zhang L, Luo M, Wang L, Li R, Wu J: Transplantation of adipose tissue lacking PAI-1 improves glucose tolerance and attenuates cardiac metabolic abnormalities in high-fat diet-induced obesity. Adipocyte 2020, 9(1):170-178.
  130. Lobeek D, Rijpkema M, Terry S, Molkenboer-Kuenen J, Joosten L, van Genugten E, van Engen-van Grunsven A, Kaanders J, Pegge S, Boerman O: Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68 Ga] Ga-DOTA-E-[c (RGDfK)] 2 PET/CT. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-9.
  131. London ED, Okita K, Kinney KR, Dean AC, McClintick MN, Rizor EJ, Johnson MC, Mahmoudie T, Brody AL, Nurmi EL: No significant elevation of translocator protein binding in the brains of recently abstinent methamphetamine users. Drug and Alcohol Dependence 2020:108104.
  132. Lu J, Bao W, Li M, Li L, Zhang Z, Alberts I, Brendel M, Cumming P, Lu H, Xiao Z: Associations of [18F]-APN-1607 Tau PET Binding in the Brain of Alzheimer’s Disease Patients With Cognition and Glucose Metabolism. Frontiers in Neuroscience 2020.
  133. Lu J, Bao W, Li M, Li L, Zhang Z, Song J, Alberts I, Brendel M, Cumming P, Zuo C: Study of Tau Deposition in Patients of Alzheimer’s Disease with [18F]-APN-1607 PET tracer and Its Relationship with Cerebral Glucose Metabolism. Journal of Nuclear Medicine 2020, 61(supplement 1):1549-1549.
  134. Lu S, Haskali MB, Ruley KM, Dreyfus NJ-F, DuBois SL, Paul S, Liow J-S, Morse CL, Kowalski A, Gladding RL: PET ligands [18F] LSN3316612 and [11C] LSN3316612 quantify O-linked-β-N-acetyl-glucosamine hydrolase in the brain. Science Translational Medicine 2020, 12(543).
  135. Lundsten S, Spiegelberg D, Raval NR, Nestor M: The radiosensitizer Onalespib increases complete remission in 177 Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-11.
  136. Mancebo DG, Becerro AI, Corral A, García-Embid S, Balcerzyk M, García ML, Jesús M, Ocaña M: Design of a nanoprobe for high field magnetic resonance imaging, dual energy X-ray computed tomography and luminescent imaging. Journal of Colloid and Interface Science 2020.
  137. Manza P, Wiers CE, Shokri-Kojori E, Kroll D, Feldman D, Schwandt M, Wang G-J, Tomasi D, Volkow ND: Brain Network Segregation and Glucose Energy Utilization: Relevance for Age-Related Differences in Cognitive Function. Cerebral Cortex 2020.
  138. Maredziak M, Bengs S, Portmann A, Haider A, Wijnen WJ, Warnock GI, Etter D, Froehlich S, Fiechter M, Meisel A: Microvascular dysfunction and sympathetic hyperactivity in women with supra-normal left ventricular ejection fraction (snLVEF). European Journal of Nuclear Medicine and Molecular Imaging 2020.
  139. Marie S, Hernández-Lozano I, Breuil L, Saba W, Novell A, Gennisson J-L, Langer O, Truillet C, Tournier N: Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [99mTc] mebrofenin Imaging in Rats. Pharmaceutics 2020, 12(6):486.
  140. Marinaro G, Huang M, Yang X, Mutschke G, Eckert K: Publications Repository-Helmholtz-Zentrum Dresden-Rossendorf. Annals of Nuclear Energy 2020, 135:106975.
  141. Masuoka T, Tateno A, Sakayori T, Tiger M, Kim W, Moriya H, Ueda S, Arakawa R, Okubo Y: Electroconvulsive Therapy Decreases Striatal Dopamine Transporter Binding in Patients with Depression: A Positron Emission Tomography Study with [18F] FE-PE2I. Psychiatry Research: Neuroimaging 2020:111086.
  142. Matsudaira T, Terada T, Obi T, Yokokura M, Takahashi Y, Ouchi Y: Coexistence of cerebral hypometabolism and neuroinflammation in the thalamo-limbic-brainstem region in young women with functional somatic syndrome. EJNMMI research 2020, 10(1):1-11.
  143. McDonald ES, Doot RK, Young AJ, Schubert EK, Tchou J, Pryma DA, Farwell MD, Nayak A, Ziober A, Feldman MD: Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status. Journal of Nuclear Medicine 2020, 61(5):665-670.
  144. McGregor M, Richer K, Ananth M, Thanos PK: The functional networks of a novel environment: Neural activity mapping in awake unrestrained rats using positron emission tomography. Brain and behavior 2020:e01646.
  145. Mehta V, Bouchareb Y, Ramaswamy S, Ahmad A, Wodehouse T, Haroon A: Metabolic Imaging of Pain Matrix Using 18F Fluoro‐deoxyglucose Positron Emission Tomography/Computed Tomography for Patients Undergoing L2 Dorsal Root Ganglion Stimulation for Low Back Pain. Neuromodulation: Technology at the Neural Interface 2020, 23(2):222-233.
  146. Michalski K, Laubner K, Stoykow C, Omrane MA, Maecke HR, Seufert J, Goetz C, Meyer PT, Ruf J: Detection of Insulinomas Using Dual-Time-Point 68Ga-DOTA-Exendin 4 PET/CT. Clinical Nuclear Medicine 2020, 45(7):519-524.
  147. Michalski K, Stoykow C, Bronsert P, Juhasz-Böss I, Meyer PT, Ruf J, Erbes T, Asberger J: Association between gastrin-releasing peptide receptor expression as assessed with [68Ga] Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer. Nuclear Medicine and Biology 2020.
  148. Mihov Y, Treyer V, Akkus F, Toman E, Milos G, Ametamey SM, Johayem A, Hasler G: Metabotropic glutamate receptor 5 in bulimia nervosa. Scientific reports 2020, 10(1):1-10.
  149. Minhas DS, Yang Z, Muschelli J, Laymon CM, Mettenburg JM, Zammit MD, Johnson S, Mathis CA, Cohen AD, Handen BL: Statistical Methods for Processing Neuroimaging Data from Two Different Sites with a Down Syndrome Population Application. In: International Conference on Information Processing and Management of Uncertainty in Knowledge-Based Systems: 2020: Springer; 2020: 367-379.
  150. Miranda A, Bertoglio D, Glorie D, Stroobants S, Staelens S, Verhaeghe J: Validation of a spatially variant resolution model for small animal brain PET studies. Biomedical Physics & Engineering Express 2020, 6(4):045001.
  151. Miyamoto M, Miyamoto T, Saitou J, Sato T: Longitudinal study of striatal aromatic l-amino acid decarboxylase activity in patients with idiopathic rapid eye movement sleep behavior disorder. Sleep Medicine 2020, 68:50-56.
  152. Miyatake Y, Mishima Y, Tsutsumi R, Otani T, Suemasa N, Masumoto S, Kuroda M, Sakaue H: Assessment of insulin resistance in the skeletal muscle of mice using positron emission tomography/computed tomography imaging. Biochemical and Biophysical Research Communications 2020.
  153. Moriguchi S, Takahata K, Shimada H, Kubota M, Kitamura S, Kimura Y, Tagai K, Tarumi R, Tabuchi H, Meyer JH: Excess tau PET ligand retention in elderly patients with major depressive disorder. Molecular Psychiatry 2020:1-8.
  154. Moriya H, Tiger M, Tateno A, Sakayori T, Masuoka T, Kim W, Arakawa R, Okubo Y: Low dopamine transporter binding in the nucleus accumbens in geriatric patients with severe depression. Psychiatry and Clinical Neurosciences 2020.
  155. Mosley M, Torres JB, Allen D, Cornelissen B: Immuno-imaging of ICAM-1 in tumours by SPECT. Nuclear Medicine and Biology 2020.
  156. Mueller A, Bullich S, Barret O, Madonia J, Berndt M, Papin C, Perrotin A, Koglin N, Kroth H, Pfeifer A: Tau PET imaging with 18F-PI-2620 in patients with Alzheimer disease and healthy controls: a first-in-humans study. Journal of Nuclear Medicine 2020, 61(6):911-919.
  157. Mutschke G, Massing J, Hossain S, Yang X, Baczyzmalski D, Cierpka C, Eckert K: Publications Repository-Helmholtz-Zentrum Dresden-Rossendorf. Annals of Nuclear Energy 2020, 135:106975.
  158. Nagachinta S, Becker G, Dammicco S, Serrano ME, Leroi N, Bahri MA, Plenevaux A, Lemaire C, Lopez R, Luxen A: Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET. Colloids and Surfaces B: Biointerfaces 2020, 188:110793.
  159. Nakaoka T, Uetake Y, Kaneko K-i, Niwa T, Ochiai H, Irie S, Suezaki Y, Otsuka N, Hayashinaka E, Wada Y: Practical synthesis of [18F] pitavastatin and evaluation of hepatobiliary transport activity in rats by positron emission tomography. Molecular Pharmaceutics 2020.
  160. Nascimento Dos Santos S, Zhang Z, Turato M, Chammas R, Lin K, Carvalho I: Synthesis and Evaluation of [18F] FEtLos and [18F] AMBF3Los as Novel 18F-Labelled Losartan Derivatives for Molecular Imaging of Angiotensin II Type 1 Receptors. Molecules (Basel, Switzerland) 2020, 25(8).
  161. Nedelcu J, Reinbach C, Riedler P, Brendel M, Rominger A, Kaye J, Behrangi N, Jiangshan Z, Schmitz C, Kipp M: Laquinimod ameliorates secondary brain inflammation. Neurobiology of disease 2020, 134:104675.
  162. Neth BJ, Mintz A, Whitlow C, Jung Y, Sai KS, Register TC, Kellar D, Lockhart SN, Hoscheidt S, Maldjian J: Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: A pilot study. Neurobiology of aging 2020, 86:54-63.
  163. Neveu M-A, Beziere N, Daniels R, Bouzin C, Comment A, Schwenck J, Fuchs K, Kneilling M, Pichler BJ, Schmid AM: Lactate Production Precedes Inflammatory Cell Recruitment in Arthritic Ankles: an Imaging Study. Molecular Imaging and Biology 2020.
  164. Nikolaus S, Beu M, Wittsack H-J, Müller-Lutz A, Antke C, Hautzel H, Mori Y, Mamlins E, Antoch G, Müller H-W: GABAergic and glutamatergic effects on nigrostriatal and mesolimbic dopamine release in the rat. Reviews in the Neurosciences 2020, 1(ahead-of-print).
  165. Niñerola-Baizán A, Aguiar P, Cabrera-Martín M, Vigil C, Gómez-Grande A, Lorenzo C, Rubí S, Sopena P, Camacho V: Relevance of quantification in brain PET studies with 18F-FDG. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2020.
  166. Nugent S, Croteau E, Potvin O, Castellano C-A, Dieumegarde L, Cunnane SC, Duchesne S: Selection of the optimal intensity normalization region for FDG-PET studies of normal aging and Alzheimer’s disease. Scientific Reports 2020, 10(1):1-8.
  167. O’Neill E, Kersemans V, Allen PD, Terry SY, Torres JB, Mosley M, Smart S, Lee BQ, Falzone N, Vallis KA: Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy. Journal of Nuclear Medicine 2020, 61(5):743-750.
  168. Oh SJ, Ahn H, Jung K-H, Han SJ, Nam KR, Kang KJ, Park J-A, Lee KC, Lee YJ, Choi JY: Evaluation of the Neuroprotective Effect of Microglial Depletion by CSF-1R Inhibition in a Parkinson’s Animal Model. Molecular Imaging and Biology 2020:1-12.
  169. Ordonez AA, Wang H, Magombedze G, Ruiz-Bedoya CA, Srivastava S, Chen A, Tucker EW, Urbanowski ME, Pieterse L, Cardozo EF: Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions. Nature medicine 2020, 26(4):529-534.
  170. Ote K, Hashimoto F, Kakimoto A, Isobe T, Inubushi T, Ota R, Tokui A, Saito A, Moriya T, Omura T: Kinetics-Induced Block Matching and 5D Transform Domain Filtering for Dynamic PET Image Denoising. IEEE Transactions on Radiation and Plasma Medical Sciences 2020.
  171. Owen J, Thomas E, Menon J, Gray M, Skaripa-Koukelli I, Gill MR, Wallington S, Miller RL, Vallis KA, Carlisle R: Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation. Journal of Controlled Release 2020, 319:222-233.
  172. Pak K, Seo S, Kim K, Lee MJ, Shin MJ, Suh S, Im HJ, Park JJ, Kim SJ, Kim IJ: Striatal dopamine transporter changes after glucose loading in humans. Diabetes, Obesity and Metabolism 2020, 22(1):116-122.
  173. Palomar-Bonet M, Atienza M, Cantero JL: Blood total antioxidant status is associated with cortical glucose uptake and factors related to accelerated aging. Brain Structure and Function 2020, 225(2):841-851.
  174. Pannell M, Economopoulos V, Wilson TC, Kersemans V, Isenegger PG, Larkin JR, Smart S, Gilchrist S, Gouverneur V, Sibson NR: Imaging of translocator protein upregulation is selective for pro‐inflammatory polarized astrocytes and microglia. Glia 2020, 68(2):280-297.
  175. Parente A, Scandiuzzi Maciel E, JO Dierckx RA, Langendijk JA, de Vries EF, Doorduin J: Delayed Effects of a Single Dose Whole-Brain Radiation Therapy on Glucose Metabolism and Myelin Density: a Longitudinal PET Study. International Journal of Radiation Biology 2020(just-accepted):1-32.
  176. Park B-N, Kim J-H, Lim TS, Park SH, Kim T-G, Yoon BS, Son KS, Yoon J-K, An Y-S: Therapeutic effect of mesenchymal stem cells in an animal model of Alzheimer’s disease evaluated by β-amyloid positron emission tomography imaging. Australian & New Zealand Journal of Psychiatry 2020:0004867420917467.
  177. Park HS, Song YS, Moon BS, Yoo S-E, Lee JM, Chung Y-T, Kim E, Lee BC, Kim SE: Neurorestorative Effects of a Novel Fas-Associated Factor 1 Inhibitor in the MPTP Model: An [18F] FE-PE2I Positron Emission Tomography Analysis Study. Frontiers in Pharmacology 2020, 11:953.
  178. Pascual B, Funk Q, Zanotti-Fregonara P, Pal N, Rockers E, Yu M, Spann B, Román GC, Schulz PE, Karmonik C: Multimodal 18F-AV-1451 and MRI Findings in Nonfluent Variant of Primary Progressive Aphasia: Possible Insights on Nodal Propagation of Tau Protein Across the Syntactic Network. Journal of Nuclear Medicine 2020, 61(2):263-269.
  179. Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Dekervel J, Van Cutsem E, Verslype C, Van Laere K, Bormans G: [18 F] AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68 Ga] Ga-DOTATATE in neuroendocrine tumour patients. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-14.
  180. Pfister J, Summer D, Petrik M, Khoylou M, Lichius A, Kaeopookum P, Kochinke L, Orasch T, Haas H, Decristoforo C: Hybrid imaging of Aspergillus fumigatus pulmonary infection with fluorescent, 68Ga-labelled siderophores. Biomolecules 2020, 10(2):168.
  181. Pinterić M, Podgorski II, Hadžija MP, Bujak IT, Dekanić A, Bagarić R, Farkaš V, Sobočanec S, Balog T: Role of Sirt3 in Differential Sex-Related Responses to a High-Fat Diet in Mice. Antioxidants 2020, 9(2):174.
  182. Polinder-Bos HA, Elting JWJ, Aries MJ, García DV, Willemsen AT, van Laar PJ, Kuipers J, Krijnen WP, Slart RH, Luurtsema G: Changes in cerebral oxygenation and cerebral blood flow during hemodialysis–A simultaneous near-infrared spectroscopy and positron emission tomography study. Journal of Cerebral Blood Flow & Metabolism 2020, 40(2):328-340.
  183. Possner M, Buechel RR, Vontobel J, Mikulicic F, Gräni C, Benz DC, Clerc OF, Fuchs TA, Tobler D, Stambach D: Myocardial blood flow and cardiac sympathetic innervation in young adults late after arterial switch operation for transposition of the great arteries. International Journal of Cardiology 2020, 299:110-115.
  184. Potemkin R, Strauch B, Kuwert T, Prante O, Maschauer S: Development of 18F-fluoroglycosylated PSMA-ligands with improved renal clearance behavior. Molecular Pharmaceutics 2020, 17(3):933-943.
  185. Pyo A, Kim D-Y, Kim H, Lim D, Kwon SY, Kang S-R, Kim H-S, Bom H-S, Min J-J: Ultrasensitive detection of malignant melanoma using PET molecular imaging probes. Proceedings of the National Academy of Sciences 2020, 117(23):12991-12999.
  186. Quelven I, Monteil J, Sage M, Saidi A, Mounier J, Bayout A, Garrier J, Cogne M, Durand-Panteix S: 212Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study. Journal of Nuclear Medicine 2020, 61(7):1058-1065.
  187. Quevenco FC, van Bergen JM, Treyer V, Studer ST, Kagerer SM, Meyer R, Gietl AF, Kaufmann PA, Nitsch RM, Hock C: Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local β-amyloid, Tau, and APOE4. Frontiers in Aging Neuroscience 2020, 12:46.
  188. Quirino TdC, Ortolan LdS, Sercundes MK, Marinho CRF, Turato WM, Epiphanio S: Lung aeration in experimental malaria-associated acute respiratory distress syndrome by SPECT/CT analysis. Plos one 2020, 15(5):e0233864.
  189. Rhodes S, Batzdorf A, Sorci O, Peng M, Jankelovits A, Hornyak J, An J, Noël PB, Høilund-Carlsen PF, Alavi A: Assessment of femoral neck bone metabolism using 18F-sodium fluoride PET/CT imaging. Bone 2020:115351.
  190. Rodríguez-Chinchilla T, Quiroga-Varela A, Molinet-Dronda F, Belloso-Iguerategui A, Merino-Galan L, Jimenez-Urbieta H, Gago B, Rodriguez-Oroz MC: [18 F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-11.
  191. Rosar F, Buchholz H-G, Michels S, Hoffmann MA, Piel M, Waldmann CM, Rösch F, Reuss S, Schreckenberger M: Image quality analysis of 44 Sc on two preclinical PET scanners: a comparison to 68 Ga. EJNMMI physics 2020, 7(1):1-17.
  192. Ruivo E, Elvas F, Adhikari K, Vangestel C, Van Haesendonck G, Lemière F, Staelens S, Stroobants S, Van der Veken P, Wyffels L: Preclinical Evaluation of a Novel 18F-Labeled dTCO-Amide Derivative for Bioorthogonal Pretargeted Positron Emission Tomography Imaging. ACS omega 2020, 5(9):4449-4456.
  193. Ruiz-Bedoya CA, Ordonez AA, Werner RA, Plyku D, Klunk MH, Leal J, Lesniak WG, Holt DP, Dannals RF, Higuchi T: 11C-PABA as a Novel PET Radiotracer for Functional Renal Imaging: Preclinical and First-in-Human Studies. Journal of Nuclear Medicine 2020:jnumed. 119.239806.
  194. Rusjan P, Sabioni P, Di Ciano P, Mansouri E, Boileau I, Laveillé A, Capet M, Duvauchelle T, Schwartz JC, Robert P: Exploring occupancy of the histamine H3 receptor by pitolisant in humans using PET. British Journal of Pharmacology 2020.
  195. Sachpekidis C, Kopp-Schneider A, Merz M, Jauch A, Raab M-S, Goldschmidt H, Dimitrakopoulou-Strauss A: Can 18F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma? Cancers 2020, 12(5):1335.
  196. Sadeghzadeh M, Wenzel B, Gündel D, Deuther-Conrad W, Toussaint M, Moldovan R-P, Fischer S, Ludwig F-A, Teodoro R, Jonnalagadda S: Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging. Molecules 2020, 25(10):2309.
  197. Sahylí Ortega Pijeira M, Sérgio Gonçalves Nunes P, Nascimento dos Santos S, Zhang Z, Pérez Nario A, Araujo Perini E, Miguel Turato W, Rodríguez Riera Z, Chammas R, H Elsinga P: Synthesis and Evaluation of [18F] FEtLos and [18F] AMBF3Los as Novel 18F-Labelled Losartan Derivatives for Molecular Imaging of Angiotensin II Type 1 Receptors. Molecules 2020, 25(8):1872.
  198. Sanaat A, Arabi H, Mainta I, Garibotto V, Zaidi H: Projection-space implementation of deep learning-guided low-dose brain PET imaging improves performance over implementation in image-space. Journal of Nuclear Medicine 2020:jnumed. 119.239327.
  199. Sang Z, Wang K, Bai P, Wu A, Shi J, Liu W, Zhu G, Wang Y, Lan Y, Chen Z: Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry 2020:112265.
  200. Schidlitzki A, Bascuñana P, Srivastava PK, Welzel L, Twele F, Töllner K, Käufer C, Gericke B, Feleke R, Meier M: Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy. Neurobiology of Disease 2020, 134:104664.
  201. Schmidt ME, Janssens L, Moechars D, Rombouts FJ, Timmers M, Barret O, Constantinescu CC, Madonia J, Russell DS, Sandiego CM: Clinical evaluation of [18 F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-10.
  202. Schneider D, Oskamp A, Holschbach M, Neumaier B, Bier D, Bauer A: Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor. Nuclear Medicine and Biology 2020, 82:1-8.
  203. Schröder S, Lai TH, Toussaint M, Kranz M, Chovsepian A, Shang Q, Dukić-Stefanović S, Deuther-Conrad W, Teodoro R, Wenzel B: PET Imaging of the Adenosine A2A Receptor in the Rotenone-Based Mouse Model of Parkinson’s Disease with [18F] FESCH Synthesized by a Simplified Two-Step One-Pot Radiolabeling Strategy. Molecules 2020, 25(7):1633.
  204. Sekine T, Buck A, Delso G, Kemp B, ter Voert EE, Huellner M, Veit-Haibach P, Kaushik S, Wiesinger F, Warnock G: The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer’s diseases—A simulation study combining multi-center data and ADNI-data. Plos one 2020, 15(6):e0233886.
  205. Serrano ME, Bahri MA, Becker G, Seret A, Germonpré C, Lemaire C, Giacomelli F, Mievis F, Luxen A, Salmon E: Exploring with [18 F] UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy. Molecular imaging and biology 2020:1-11.
  206. Shah S, Sinharay S, Matsuda K, Schreiber-Stainthorp W, Muthusamy S, Lee D, Wakim P, Hirsch V, Nath A, Di Mascio M: 11C-DASB PET. Identifying Neuroimaging-Based Markers for Distinguishing Brain Disorders 2020.
  207. Shiiba T, Arimura Y, Nagano M, Takahashi T, Takaki A: Improvement of classification performance of Parkinson’s disease using shape features for machine learning on dopamine transporter single photon emission computed tomography. PloS one 2020, 15(1):e0228289.
  208. Shimada H, Minatani S, Takeuchi J, Takeda A, Kawabe J, Wada Y, Mawatari A, Watanabe Y, Shimada H, Higuchi M: Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer’s Disease with APP Osaka Mutation. International Journal of Molecular Sciences 2020, 21(12):4443.
  209. Shimojo M, Takuwa H, Takado Y, Tokunaga M, Tsukamoto S, Minatohara K, Ono M, Seki C, Maeda J, Urushihata T: Selective disruption of inhibitory synapses leading to neuronal hyperexcitability at an early stage of tau pathogenesis in a mouse model. Journal of Neuroscience 2020, 40(17):3491-3501.
  210. Shimokawa N, Akamatsu G, Kadosaki M, Sasaki M: Feasibility study of a PET-only amyloid quantification method: a comparison with visual interpretation. Annals of Nuclear Medicine 2020:1-7.
  211. Shin U, Kim J, Lee J, Park D, Lee C, Jung HC, Park J, Lee K, Lee MW, Kim SW: Development of 64Cu-loaded Perfluoropentane Nanodroplet: A Potential Tumor Theragnostic Nano-carrier and Dual-Modality PET-Ultrasound Imaging Agents. Ultrasound in Medicine & Biology 2020.
  212. Shrestha S, Kim M-J, Eldridge M, Lehmann ML, Frankland M, Liow J-S, Yu Z-X, Cortes-Salva M, Telu S, Henter ID: PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study. Journal of Neuroinflammation 2020, 17:1-17.
  213. Smith R, Schöll M, Leuzy A, Jögi J, Ohlsson T, Strandberg O, Hansson O: Head-to-head comparison of tau positron emission tomography tracers [18 F] flortaucipir and [18 F] RO948. European journal of nuclear medicine and molecular imaging 2020, 47(2):342-354.
  214. Smyczyńska U, Strzemecki D, Czarnecka AM, Fendler W, Fiedorowicz M, Wełniak-Kamińska M, Guzowska M, Synoradzki K, Cheda Ł, Rogulski Z: TP53-Deficient Angiosarcoma Expression Profiling in Rat Model. Cancers 2020, 12(6):1525.
  215. Snitz BE, Tudorascu DL, Yu Z, Campbell E, Lopresti BJ, Laymon CM, Minhas DS, Nadkarni NK, Aizenstein HJ, Klunk WE: Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non‐demented older adults. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 2020, 12(1):e12018.
  216. Souza Vieira S, Antonio EL, de Melo BL, Neves dos Santos LF, Santana ET, Feliciano R, Marques FLN, de Paula Faria D, Buchpiguel CA, Silva JA: Increased Myocardial Retention of Mesenchymal Stem Cells Post-MI by Pre-Conditioning Exercise Training. Stem Cell Reviews and Reports 2020:1-12.
  217. Spath N, Tavares A, Gray GA, Baker AH, Lennen RJ, Alcaide-Corral CJ, Dweck MR, Newby DE, Yang PC, Jansen MA: Manganese-enhanced T 1 mapping to quantify myocardial viability: validation with 18 F-fluorodeoxyglucose positron emission tomography. Scientific Reports 2020, 10(1):1-10.
  218. Stanford D, Kim H, Bodduluri S, LaFontaine J, Byzek SA, Schoeb TR, Harris ES, Nath HP, Bhatt SP, Raju SV: Airway Remodeling in Ferrets with Cigarette Smoke Induced COPD using µCT Imaging. American Journal of Physiology-Lung Cellular and Molecular Physiology 2020.
  219. Steffen DA, Giannopoulos AA, Grossmann M, Messerli M, Schwyzer M, Gräni C, Gebhard C, Pazhenkottil AP, Kaufmann PA, Buechel RR: “Apical thinning”: Relations between myocardial wall thickness and apical left ventricular tracer uptake as assessed with positron emission tomography myocardial perfusion imaging. Journal of Nuclear Cardiology 2020, 27(2):452-460.
  220. Stegmayr C, Surges R, Choi C-H, Burda N, Stoffels G, Filß C, Willuweit A, Neumaier B, Heinzel A, Shah NJ: Investigation of Cerebral O-(2-[18 F] Fluoroethyl)-L-Tyrosine Uptake in Rat Epilepsy Models. Molecular imaging and biology 2020.
  221. Stojakovic A, Trushin S, Sheu A, Khalili L, Chang S-Y, Li X, Christensen T, Salisbury JL, Geroux RE, Gateno B: Partial inhibition of mitochondrial complex I attenuates neurodegeneration and restores energy homeostasis and synaptic function in a symptomatic Alzheimers mouse model. bioRxiv 2020.
  222. Strähl M, Schindler M, Keller LS, Holy E, Jakob P, Siegrist PT, Templin C, Maier W, Buechel RR, Kaufmann PA: Diagnostic performance of angiography-based quantitative flow ratio for the identification of myocardial ischemia as assessed by 13N-ammonia myocardial perfusion imaging positron emission tomography. International Journal of Cardiology 2020.
  223. Stutvoet TS, van der Veen EL, Kol A, Antunes IF, de Vries EF, Hospers GA, de Vries EG, de Jong S, Lub-de Hooge MN: Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer 18F-BMS-986192. Journal of Nuclear Medicine 2020:jnumed. 119.241364.
  224. Summer D, Petrik M, Mayr S, Hermann M, Kaeopookum P, Pfister J, Klingler M, Rangger C, Haas H, Decristoforo C: Hybrid Imaging Agents for Pretargeting Applications Based on Fusarinine C—Proof of Concept. Molecules 2020, 25(9):2123.
  225. Svirydenka H, Muehlematter UJ, Nagel HW, Delso G, Ferraro DA, Kudura K, Burger IA, Ter Voert EE: 68 Ga-PSMA-11 dose reduction for dedicated pelvic imaging with simultaneous PET/MR using TOF BSREM reconstructions. European Radiology 2020:1-10.
  226. Tada T, Ito Y, Murayama R, Tamura M, Tsutsumi Y, Kato K, Ochi Y, Ikeda H: Comparative Study of Various Reference Regions for Standardized Uptake Value Ratio Using11C-Pittsburgh Compound-B PET and MR Images. Journal of Nuclear Medicine 2020, 61(supplement 1):3099-3099.
  227. Tagai K, Ono M, Kubota M, Kitamura S, Takahata K, Seki C, Takado Y, Shinotoh H, Sano Y, Matsuoka K: High-contrast in-vivo imaging of tau pathologies in Alzheimer’s and non-Alzheimer’s disease tauopathies. medRxiv 2020.
  228. Tago T, Toyohara J, Ishii K: Radiosynthesis and preliminary evaluation of an 18F‐labeled tubastatin A analog for PET imaging of histone deacetylase 6. Journal of Labelled Compounds and Radiopharmaceuticals 2020, 63(2):85-95.
  229. Takeuchi H, Imamura K, Ji B, Tsukita K, Enami T, Takao K, Miyakawa T, Hasegawa M, Sahara N, Iwata N: Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice. npj Vaccines 2020, 5(1):1-11.
  230. Terada T, Obi T, Bunai T, Matsudaira T, Yoshikawa E, Ando I, Futatsubashi M, Tsukada H, Ouchi Y: In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease. Neurology 2020, 94(15):e1592-e1604.
  231. Térence T, Cawthorne C, Kim S, Elin P, Willy G, Guy B, Deroose CM, Frederik C: Automated GMP compliant production of [18 F] AlF-NOTA-octreotide. EJNMMI Radiopharmacy and Chemistry 2020, 5(1).
  232. Thiele S, Sörensen A, Weis J, Braun F, Meyer PT, Coenen VA, Döbrössy MD: Deep Brain Stimulation of the Medial Forebrain Bundle in a Rodent Model of Depression: Exploring Dopaminergic Mechanisms with Raclopride and Micro-PET. Stereotactic and Functional Neurosurgery 2020, 98(1):8-20.
  233. Thomsen MB, Jacobsen J, Lillethorup TP, Schacht AC, Simonsen M, Romero-Ramos M, Brooks DJ, Landau AM: In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C] UCB-J PET. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X20931140.
  234. Thomsen MB, Schacht AC, Alstrup AKO, Jacobsen J, Lillethorup TP, Bærentzen SL, Noer O, Orlowski D, Elfving B, Müller HK: Preclinical PET Studies of [11 C] UCB-J Binding in Minipig Brain. Molecular Imaging and Biology 2020.
  235. Thomsen MK, Skouboe MK, Boularan C, Vernejoul F, Lioux T, Leknes SL, Berthelsen MF, Riedel M, Cai H, Joseph JV: The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma. Oncogene 2020, 39(8):1652-1664.
  236. Tjerkaski J, Cervenka S, Farde L, Matheson GJ: Kinfitr–an open source tool for reproducible PET modelling: validation and evaluation of test-retest reliability. BioRxiv 2020.
  237. Tjörnstrand A, Casar‐Borota O, Heurling K, Schöll M, Gjertsson P, Himmelman J, Itsenko O, Ragnarsson O, Filipsson Nyström H: Lower 68Ga‐DOTATOC uptake in nonfunctioning pituitary neuroendocrine tumours compared to normal pituitary gland—A proof‐of‐concept study. Clinical Endocrinology 2020, 92(3):222-231.
  238. Tobey H, Lucas T, Paul S, Berr SS, Mehrkens B, Brolinson PG, Klein BG, Costa BM: Mechanoceutics Alters Alzheimer’s Disease Phenotypes in Transgenic Rats: A Pilot Study. Journal of Alzheimer’s Disease 2020(Preprint):1-7.
  239. Toms J, Kogler J, Maschauer S, Daniel C, Schmidkonz C, Kuwert T, Prante O: Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18F-labeled FAP Inhibitor. Journal of Nuclear Medicine 2020:jnumed. 120.242958.
  240. Toramatsu C, Mohammadi A, Wakizaka H, Seki C, Nishikido F, Sato S, Kanno I, Takahashi M, Karasawa K, Hirano Y: Biological washout modelling for in-beam PET: rabbit brain irradiation by 11C and 15O ion beams. Physics in Medicine & Biology 2020, 65(10):105011.
  241. Tournier BB, Tsartsalis S, Ceyzériat K, Medina Z, Fraser BH, Grégoire M-C, Kövari E, Millet P: Fluorescence-activated cell sorting to reveal the cell origin of radioligand binding. Journal of Cerebral Blood Flow & Metabolism 2020, 40(6):1242-1255.
  242. Toussaint M, Deuther-Conrad W, Kranz M, Fischer S, Ludwig F-A, Juratli TA, Patt M, Wünsch B, Schackert G, Sabri O: Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (S)-(−)-[18F] Fluspidine in Glioblastoma. Molecules 2020, 25(9):2170.
  243. Tsartsalis S, Tournier BB, Millet P: In vivo absolute quantification of striatal and extrastriatal D 2/3 receptors with [123 I] epidepride SPECT. EJNMMI research 2020, 10(1):1-14.
  244. Tshibangu T, Cawthorne C, Serdons K, Pauwels E, Gsell W, Bormans G, Deroose CM, Cleeren F: Automated GMP compliant production of [18 F] AlF-NOTA-octreotide. EJNMMI radiopharmacy and chemistry 2020, 5(1):4.
  245. Van Camp N, Balbastre Y, Herard A-S, Lavisse S, Tauber C, Wimberley C, Guillermier M, Berniard A, Gipchtein P, Jan C: Assessment of simplified methods for quantification of [18F]-DPA-714 using 3D whole-brain TSPO immunohistochemistry in a non-human primate. Journal of Cerebral Blood Flow & Metabolism 2020, 40(5):1103-1116.
  246. van der Veen EL, Suurs FV, Cleeren F, Bormans G, Elsinga PH, Hospers GA, Lub-de Hooge MN, de Vries EG, de Vries EF, Antunes IF: Development and evaluation of interleukin-2 derived radiotracers for PET imaging of T-cells in mice. Journal of Nuclear Medicine 2020:jnumed. 119.238782.
  247. van der Weide H, Cossío U, Gracia R, Te Welscher YM, Marian T, van der Meijden A, Marradi M, Ritsema JA, Vermeulen-de Jongh DM, Storm G: Therapeutic efficacy of novel antimicrobial peptide AA139-nanomedicines in a multidrug-resistant Klebsiella pneumoniae pneumonia-septicemia model in rats. Antimicrobial Agents and Chemotherapy 2020.
  248. Van Weehaeghe D, Babu S, De Vocht J, Zurcher NR, Chew S, Tseng C-EJ, Loggia M, Koole M, Rezaei A, Schramm G: Moving towards multicenter therapeutic trials in ALS: feasibility of data pooling using different TSPO positron emission tomography (PET) radioligands. Journal of Nuclear Medicine 2020:jnumed. 119.241059.
  249. Van Weehaeghe D, Van Schoor E, De Vocht J, Koole M, Attili B, Celen S, Declercq L, Thal DR, Van Damme P, Bormans G: TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study. Journal of Nuclear Medicine 2020, 61(4):604-607.
  250. Vandergaast R, Khongwichit S, Jiang H, DeGrado TR, Peng K-W, Smith DR, Russell SJ, Suksanpaisan L: Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging. Cancer Gene Therapy 2020, 27(3):179-188.
  251. Vanhaute H, Ceccarini J, Michiels L, Koole M, Sunaert S, Lemmens R, Triau E, Emsell L, Vandenbulcke M, Van Laere K: In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment. Neurology 2020.
  252. Vega SC, Leiss V, Piekorz R, Calaminus C, Pexa K, Vuozzo M, Schmid AM, Devanathan V, Kesenheimer C, Pichler BJ: Selective protection of murine cerebral G i/o-proteins from inactivation by parenterally injected pertussis toxin. Journal of Molecular Medicine 2020, 98(1):97-110.
  253. Verhoeven J, Baguet T, Piron S, Pauwelyn G, Bouckaert C, Descamps B, Raedt R, Vanhove C, De Vos F, Goethals I: 2-[18F] FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation. Nuclear Medicine and Biology 2020, 82:9-16.
  254. Vetel S, Vercouillie J, Buron F, Vergote J, Tauber C, Busson J, Chicheri G, Routier S, Sérrière S, Chalon S: Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [18 F] ASEM in a Rat Model of Parkinson’s Disease. Molecular Imaging and Biology 2020, 22(2):348-357.
  255. Vignal N, Boulay A-C, San C, Cohen-Salmon M, Rizzo-Padoin N, Sarda-Mantel L, Declèves X, Cisternino S, Hosten B: Astroglial Connexin 43 Deficiency Protects against LPS-Induced Neuroinflammation: A TSPO Brain µPET Study with [18F] FEPPA. Cells 2020, 9(2):389.
  256. Vigne J, Cabella C, Dézsi L, Rustique E, Couffin A-C, Aid R, Anizan N, Chauvierre C, Letourneur D, Le Guludec D: Nanostructured lipid carriers accumulate in atherosclerotic plaques of ApoE−/− mice. Nanomedicine: Nanotechnology, Biology and Medicine 2020, 25:102157.
  257. Wakabayashi Y, Telu S, Dick RM, Fujita M, Ooms M, Morse CL, Liow J-S, Hong JS, Gladding RL, Manly LS: Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4D. ACS Chemical Neuroscience 2020, 11(9):1311-1323.
  258. Wang PN, Lin KJ, Liu HC, Andreasson U, Blennow K, Zetterberg H, Yang SY: Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 2020, 12(1):e12029.
  259. Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer BM: On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D 2/3 receptor agonist radioligand study. Translational psychiatry 2020, 10(1):1-11.
  260. Weng C-C, Hsiao I-T, Yang Q-F, Yao C-H, Tai C-Y, Wu M-F, Yen T-C, Jang M-K, Lin K-J: Characterization of 18F-PM-PBB3 (18F-APN-1607) Uptake in the rTg4510 Mouse Model of Tauopathy. Molecules 2020, 25(7):1750.
  261. Workman CD, Ponto LLB, Kamholz J, Rudroff T: No immediate effects of transcranial direct current stimulation at various intensities on cerebral blood flow in people with multiple sclerosis. Brain Sciences 2020, 10(2):82.
  262. Yeh CI, Cheng MF, Xiao F, Chen YC, Liu CC, Chen HY, Yen RF, Ju YT, Chen Y, Bodduluri M: Effects of Focal Radiation on [18F]‐Fluoro‐D‐Glucose Positron Emission Tomography in the Brains of Miniature Pigs: Preliminary Findings on Local Metabolism. Neuromodulation: Technology at the Neural Interface 2020.
  263. Yeh SH-H, Shie F-S, Liu H-K, Yao H-H, Kao P-C, Lee Y-H, Chen L-M, Hsu S-M, Chao L-J, Wu K-W: A high-sucrose diet aggravates Alzheimer’s disease pathology, attenuates hypothalamic leptin signaling, and impairs food-anticipatory activity in APPswe/PS1dE9 mice. Neurobiology of aging 2020, 90:60-74.
  264. Yokokura M, Takebasashi K, Takao A, Nakaizumi K, Yoshikawa E, Futatsubashi M, Suzuki K, Nakamura K, Yamasue H, Ouchi Y: In vivo imaging of dopamine D1 receptor and activated microglia in attention-deficit/hyperactivity disorder: a positron emission tomography study. Molecular Psychiatry 2020:1-10.
  265. Yoon J-K, Byeon HE, Ko SA, Park B-N, An Y-S, Lee H-Y, Lee YW, Lee SJ: cell cycle synchronisation using thiazolidinediones affects cellular glucose metabolism and enhances the therapeutic effect of 2-deoxyglucose in colon cancer. Scientific reports 2020, 10(1):1-7.
  266. Zaibaq NG, Pollard AC, Collins MJ, Pisaneschi F, Pagel MD, Wilson LJ: Evaluation of the Biodistribution of Serinolamide-Derivatized C60 Fullerene. Nanomaterials 2020, 10(1):143.
  267. Zhang Y, García-Gabilondo M, Grayston A, Feiner IV, Anton-Sales I, Loiola RA, Llop J, Ramos-Cabrer P, Barba I, Garcia-Dorado D: PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities. Nanoscale 2020, 12(8):4988-5002.
  268. Zhao J, Wen X, Li T, Shi S, Xiong C, Wang YA, Li C: Concurrent Injection of Unlabeled Antibodies Allows Positron Emission Tomography Imaging of Programmed Cell Death Ligand 1 Expression in an Orthotopic Pancreatic Tumor Model. ACS omega 2020, 5(15):8474-8482.
  269. Zhou C, Guan XJ, Guo T, Zeng QL, Gao T, Huang PY, Xuan M, Gu QQ, Xu XJ, Zhang MM: Progressive brain atrophy in Parkinson’s disease patients who convert to mild cognitive impairment. CNS neuroscience & therapeutics 2020, 26(1):117-125.
  270. Zhu Y, Fiedler SA, Hibert ML, Wang C: Synthesis of a carbon-11 radiolabeled BACE1 inhibitor. Medicinal Chemistry Research 2020, 29(2):262-267.
  271. Zou J, Tao S, Johnson A, Tomljanovic Z, Polly K, Klein J, Razlighi QR, Brickman AM, Lee S, Stern Y: Microglial activation, but not tau pathology, is independently associated with amyloid positivity and memory impairment. Neurobiology of aging 2020, 85:11-21.
  272. Zoufal V, Mairinger S, Brackhan M, Krohn M, Filip T, Sauberer M, Stanek J, Wanek T, Tournier N, Bauer M: Imaging P-Glycoprotein Induction at the Blood–Brain Barrier of a β-Amyloidosis Mouse Model with 11C-Metoclopramide PET. Journal of Nuclear Medicine 2020, 61(7):1050-1057.
  273. Zoufal V, Mairinger S, Krohn M, Wanek T, Filip T, Sauberer M, Stanek J, Kuntner C, Pahnke J, Langer O: Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomography. Journal of Cerebral Blood Flow & Metabolism 2020, 40(5):954-965.
  274. Zoufal V, Wanek T, Krohn M, Mairinger S, Filip T, Sauberer M, Stanek J, Pekar T, Bauer M, Pahnke J: Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET. Journal of Cerebral Blood Flow & Metabolism 2020, 40(1):150-162.
  275. Zürcher N, Loggia M, Mullett J, Tseng C, Bhanot A, Richey L, Hightower B, Wu C, Parmar A, Butterfield R: [11 C] PBR28 MR–PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder. Molecular Psychiatry 2020:1-11.